Suppr超能文献

通过平面闪烁扫描法和SPECT/CT检测妇科肿瘤前哨淋巴结

Detection of Sentinel Lymph Nodes in Gynecologic Tumours by Planar Scintigraphy and SPECT/CT.

作者信息

Kraft Otakar, Havel Martin

机构信息

University Hospital, Clinic of Nuclear Medicine, Ostrava, Poruba, Czech Republic ; University of Ostrava, Faculty of Medicine, Ostrava, Czech Republic.

出版信息

Mol Imaging Radionucl Ther. 2012 Aug;21(2):47-55. doi: 10.4274/Mirt.236. Epub 2012 Aug 1.

Abstract

OBJECTIVE

Assess the role of planar lymphoscintigraphy and fusion imaging of SPECT/CT in sentinel lymph node (SLN) detection in patients with gynecologic tumours.

MATERIAL AND METHODS

Planar scintigraphy and hybrid modality SPECT/CT were performed in 64 consecutive women with gynecologic tumours (mean age 53.6 with range 30-77 years): 36 pts with cervical cancer (Group A), 21 pts with endometrial cancer (Group B), 7 pts with vulvar carcinoma (Group C). Planar and SPECT/CT images were interpreted separately by two nuclear medicine physicians. Efficacy of these two techniques to image SLN were compared.

RESULTS

Planar scintigraphy did not image SLN in 7 patients (10.9%), SPECT/CT was negative in 4 patients (6.3%). In 35 (54.7%) patients the number of SLNs captured on SPECT/CT was higher than on planar imaging. Differences in detection of SLN between planar and SPECT/CT imaging in the group of all 64 patients are statistically significant (p<0.05). Three foci of uptake (1.7% from totally visible 177 foci on planar images) in 2 patients interpreted on planar images as hot LNs were found to be false positive non-nodal sites of uptake when further assessed on SPECT/CT. SPECT/CT showed the exact anatomical location of all visualised sentinel nodes.

CONCLUSION

In some patients with gynecologic cancers SPECT/CT improves detection of sentinel lymph nodes. It can image nodes not visible on planar scintigrams, exclude false positive uptake and exactly localise pelvic and paraaortal SLNs. It improves anatomic localization of SLNs.

CONFLICT OF INTEREST

None declared.

摘要

目的

评估平面淋巴闪烁显像及SPECT/CT融合成像在妇科肿瘤患者前哨淋巴结(SLN)检测中的作用。

材料与方法

对64例连续的妇科肿瘤女性患者(平均年龄53.6岁,范围30 - 77岁)进行平面闪烁显像及SPECT/CT混合模式检查:36例宫颈癌患者(A组),21例子宫内膜癌患者(B组),7例外阴癌患者(C组)。两名核医学医师分别解读平面及SPECT/CT图像。比较这两种技术对SLN成像的效果。

结果

平面闪烁显像在7例患者(10.9%)中未显示SLN,SPECT/CT在4例患者(6.3%)中呈阴性。在35例(54.7%)患者中,SPECT/CT捕获的SLN数量多于平面显像。64例患者组中平面显像与SPECT/CT成像在SLN检测上的差异具有统计学意义(p<0.05)。在2例患者的平面图像上被解读为热淋巴结的3个摄取灶(占平面图像上总共可见的177个灶的1.7%),在进一步通过SPECT/CT评估时被发现是假阳性的非淋巴结摄取部位。SPECT/CT显示了所有可视化前哨淋巴结的确切解剖位置。

结论

在一些妇科癌症患者中,SPECT/CT可改善前哨淋巴结的检测。它能显示平面闪烁显像上不可见的淋巴结,排除假阳性摄取,并准确确定盆腔及腹主动脉旁SLN的位置。它改善了SLN的解剖定位。

利益冲突

未声明。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40a7/3590971/782ee0530adf/MIRT-21-47-g1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验